Beijing朗视 Instrument Co., Ltd.

Beijing Langshi Instrument Co., Ltd. (hereinafter referred to as "Langshi Instrument") is a high-tech company providing high-end medical device products and services, and is a national-level "Little Giant" enterprise specializing in new technologies, recognized by the Ministry of Industry and Information Technology. Langshi Instrument's products cover oral cone-beam CT (oral CBCT), oral medical imaging processing software, orthodontic appliances and software, and imaging cloud technology services, meeting various clinical needs. With the mission of "providing better products and services to doctors and patients," Langshi Instrument independently developed the oral CBCT, which obtained the first domestic medical device registration certificate for sitting-type oral CBCT and is also the first similar product in China to pass EU CE certification. Currently, the performance, quality, and service of the oral CBCT series products have been widely recognized in the market, with rapid and sustained growth in performance. Customers are spread across all provinces, municipalities, and autonomous regions nationwide, and products are exported to Europe, Africa, Southeast Asia, the Middle East, and other countries and regions. Since its establishment, Langshi Instrument has always regarded "becoming an excellent medical device manufacturer" as its development vision, actively promoting the formulation of industry standards. It is one of the drafting units for multiple domestic imaging equipment industry standards and, as a Chinese expert representative, participated in the development of the international IEC standard for oral X-ray products. The oral CBCT series products have reached the international advanced level overall, with spatial resolution and the performance indicators of the "four-in-one" multifunctional equipment reaching a leading level. The core technical team of Langshi Instrument originates from Tsinghua University and Nuctech Technology Co., Ltd., possessing extensive technical accumulation and a large amount of independent intellectual property in high-precision CBCT imaging, dose optimization, high-precision electromechanical system design, artifact correction, and image processing. To date, the company has obtained more than 60 patents, nearly 20 registered trademarks, and over 10 software copyrights. Additionally, guided by clinical needs, Langshi Instrument continuously increases R&D investment, explores scientific frontiers, and, together with Tsinghua University, Peking University School and Hospital of Stomatology, Capital Medical University, and other institutions, has undertaken multiple national scientific research projects, including the Twelfth Five-Year National Science and Technology Support Program, the Thirteenth Five-Year National Key Research and Development Program, the National Natural Science Foundation Major Instrument Projects, the National Key Research and Development Program (Technology Winter Olympics special project), and the National Key Research and Development Program (Additive Manufacturing and Laser Manufacturing special project), fostering mutual promotion and common development among industry, academia, research, and medicine. In the future, Langshi Instrument will remain true to its original aspiration and mission, providing better products and services to doctors and patients, and contributing its strength to the cause of human medical health!